text stringlengths 2 4.03k | query stringlengths 1 194 | file_name stringclasses 60
values | file_class stringclasses 4
values | type stringclasses 2
values | general_chunk_id int64 0 3.1k |
|---|---|---|---|---|---|
erate intensity aerobic activity. However, a careful review of her
health screening questionnaire reveals she is taking propranolol
for prevention of migraines. Propranolol is a beta-blocker, a | effect of propranolol on aerobic exercise performance | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 21 |
erate intensity aerobic activity. However, a careful review of her
health screening questionnaire reveals she is taking propranolol
for prevention of migraines. Propranolol is a beta-blocker, a | beta-blockers and exercise intensity recommendations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 21 |
erate intensity aerobic activity. However, a careful review of her
health screening questionnaire reveals she is taking propranolol
for prevention of migraines. Propranolol is a beta-blocker, a | propranolol impact on heart rate during aerobic activity | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 21 |
erate intensity aerobic activity. However, a careful review of her
health screening questionnaire reveals she is taking propranolol
for prevention of migraines. Propranolol is a beta-blocker, a | exercise guidelines for individuals taking beta-blockers | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 21 |
erate intensity aerobic activity. However, a careful review of her
health screening questionnaire reveals she is taking propranolol
for prevention of migraines. Propranolol is a beta-blocker, a | migraine medication propranolol and exercise limitations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 21 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | beta-blockers effect on heart rate during exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | adjusting target heart rate for clients on beta-blockers | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | medication adherence factors in chronic conditions | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | role of exercise professionals in medication management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | using perceived exertion instead of heart rate for beta-blocker users | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | effect of beta-blockers on heart rate during exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | how to adjust target heart rate for clients on beta-blockers | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | using perceived exertion instead of heart rate for beta-blocker users | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | medication adherence factors in exercise clients | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 22 |
type of medication that is commonly used to treat high blood
pressure or other heart conditions. Regardless of the reason
for the prescription, the medication will influence heart rate
(lower at rest and during exercise) and blood pressure (lower at rest and during exercise). Given the client is apparently
healthy and ... | role of exercise professionals in medication management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 22 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | exercise and glucose uptake in type 1 diabetes | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | managing hypoglycemia during exercise for type 1 diabetes | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | role of exercise professionals in diabetes management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | insulin adjustment and exercise for type 1 diabetes | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | scope of practice for exercise professionals with diabetic clients | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | exercise and hypoglycemia in type 1 diabetes | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | managing low blood glucose during physical activity for diabetics | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | role of exercise in glucose uptake for insulin users | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | when to consult a doctor about insulin and exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 23 |
sionals should not provide medical advice or medical opinions
(e.g., that taking a particular drug will provide a desired out-
come). While staying within an appropriate scope of practice,
clients can be encouraged to contact their healthcare provider regarding medication-related questions or concerns.
For example, a c... | how exercise professionals should handle client medication questions | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 23 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | medications impact on exercise response and safety considerations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | exercise prescription guidelines for clients on medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | scope of practice for exercise professionals regarding medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | ACSM guidelines for medication review in exercise testing | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | preparticipation health screening and medication considerations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | medications impact on exercise response | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | safe exercise prescription with medication review | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | exercise professional guidelines for medication considerations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | how to review client medications for exercise safety | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 24 |
the potential impact of many medications on exercise response,
exercise professionals can promote safe and effective exercise
testing/prescription with a careful review of current medica-
tions. Reviewing the client's list of medications provided on their health screening questionnaire and using reputable sources will
... | ACSM guidelines for exercise testing with medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 24 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | common prescription medications among adults | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | top 200 drugs of 2022 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | semaglutide drug information | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | prescription medication use statistics | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | cardiovascular pulmonary metabolic orthopedic medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | most common prescription medications 2023 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | top 200 drugs of 2022 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | semaglutide prescription statistics | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | prescription medication use among adults CDC | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 25 |
Professional's Handbook. 8th ed. Champaign (IL): Human Kinetics; 2025.
pp. 19–53.
4. Centers for Disease Control and Prevention. Health, United States—Data Finder. [cited 2024 August 12]. Available from: www.cdc.gov/nchs/hus/
data-finder.htm.
5. National Center for Health Statistics Data Query System. Prescription medi... | cardiovascular pulmonary metabolic orthopedic medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 25 |
and neuromuscular) for those interested in learning more.
Thompson WR, Ozemek C. ACSM's Clinical Exercise
Physiology. 2nd Ed. Philadelphia (PA): Wolters Kluwer. 2024. ISBN 9781975234690.
Learn more about this book here:
https://www.acsm.org/education-resources/books/
clinical-exercise-physiology
WOULDN'T YOU LIKE TO KN... | ACSM Clinical Exercise Physiology 2nd Edition | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 26 |
and neuromuscular) for those interested in learning more.
Thompson WR, Ozemek C. ACSM's Clinical Exercise
Physiology. 2nd Ed. Philadelphia (PA): Wolters Kluwer. 2024. ISBN 9781975234690.
Learn more about this book here:
https://www.acsm.org/education-resources/books/
clinical-exercise-physiology
WOULDN'T YOU LIKE TO KN... | neuromuscular aspects of exercise physiology | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 26 |
and neuromuscular) for those interested in learning more.
Thompson WR, Ozemek C. ACSM's Clinical Exercise
Physiology. 2nd Ed. Philadelphia (PA): Wolters Kluwer. 2024. ISBN 9781975234690.
Learn more about this book here:
https://www.acsm.org/education-resources/books/
clinical-exercise-physiology
WOULDN'T YOU LIKE TO KN... | ACSM Health & Fitness Journal March/April 2025 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 26 |
and neuromuscular) for those interested in learning more.
Thompson WR, Ozemek C. ACSM's Clinical Exercise
Physiology. 2nd Ed. Philadelphia (PA): Wolters Kluwer. 2024. ISBN 9781975234690.
Learn more about this book here:
https://www.acsm.org/education-resources/books/
clinical-exercise-physiology
WOULDN'T YOU LIKE TO KN... | clinical exercise physiology textbook Wolters Kluwer | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 26 |
and neuromuscular) for those interested in learning more.
Thompson WR, Ozemek C. ACSM's Clinical Exercise
Physiology. 2nd Ed. Philadelphia (PA): Wolters Kluwer. 2024. ISBN 9781975234690.
Learn more about this book here:
https://www.acsm.org/education-resources/books/
clinical-exercise-physiology
WOULDN'T YOU LIKE TO KN... | ACSM educational resources on exercise physiology | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 26 |
9. Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug
expenditures and projections for 2024. Am J Health-Syst Pharm. 2024;81(14): | national trends prescription drug expenditures 2024 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 27 |
9. Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug
expenditures and projections for 2024. Am J Health-Syst Pharm. 2024;81(14): | projections prescription drug costs 2024 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 27 |
9. Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug
expenditures and projections for 2024. Am J Health-Syst Pharm. 2024;81(14): | pharmaceutical spending trends United States | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 27 |
9. Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug
expenditures and projections for 2024. Am J Health-Syst Pharm. 2024;81(14): | Am J Health-Syst Pharm prescription drug expenditures | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 27 |
9. Tichy EM, Hoffman JM, Tadrous M, et al. National trends in prescription drug
expenditures and projections for 2024. Am J Health-Syst Pharm. 2024;81(14): | healthcare pharmacy expenditure projections 2024 | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 27 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | adverse drug reactions clinical pharmacology | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | types of blood pressure medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | antidepressant drugs effects on blood pressure | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | pseudoephedrine benefits and risks | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | over-the-counter OTC medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | effects of antidepressant drugs on blood pressure | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | benefits and risks of pseudoephedrine | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | types of blood pressure medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | adverse drug reactions in clinical pharmacology | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 28 |
583–98.
10. International Union of Basic and Clinical Pharmacology. Pharmacology
education project. [cited 2024 August 23]. Available from: https://www. pharmacologyeducation.org/clinical-pharmacology/adverse-drug-reactions.
11. American Heart Association. Website [Internet]. Types of blood pressure medications. Dallas... | over-the-counter medications and their uses | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 28 |
2024 Aug 20]. Available from: https://www.rxlist.com/over-the-counter_otc_
medicines/drugs-condition.htm. | OTC medicines list and conditions treated | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 29 |
2024 Aug 20]. Available from: https://www.rxlist.com/over-the-counter_otc_
medicines/drugs-condition.htm. | over-the-counter drugs for common ailments | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 29 |
2024 Aug 20]. Available from: https://www.rxlist.com/over-the-counter_otc_
medicines/drugs-condition.htm. | RxList OTC medications reference | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 29 |
2024 Aug 20]. Available from: https://www.rxlist.com/over-the-counter_otc_
medicines/drugs-condition.htm. | OTC drug database for symptom relief | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 29 |
2024 Aug 20]. Available from: https://www.rxlist.com/over-the-counter_otc_
medicines/drugs-condition.htm. | list of over-the-counter medicines by condition | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 29 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Cardiovascular effects and safety of non-aspirin NSAIDs | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Steroid hyperglycemia prevalence and therapeutic recommendations | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Second generation antipsychotics and glucose metabolism dysregulation | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Statin-associated muscle disease diagnosis and management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Fluoroquinolones and risk of tendon injury systematic review | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | NSAIDs cardiovascular effects and safety | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Steroid hyperglycemia prevalence and management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Second generation antipsychotics glucose metabolism dysregulation | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Statin-associated muscle disease diagnosis and management | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 30 |
16. Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–84. doi:10.1038/
s41569-020-0366-z. 17. Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid
hyperglycemia: prevalence, early detection and therapeutic recommen... | Fluoroquinolones risk of tendon injury | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 30 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | caffeine effects on diuresis during rest and exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | meta-analysis of caffeine and diuresis in sports | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | methods for estimating maximal heart rate | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | clinical guidance on heat and medications | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | relationship between caffeine intake and diuresis in athletes | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | caffeine effects on diuresis during exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | meta-analysis caffeine diuresis rest exercise | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | how does caffeine affect urine output during physical activity | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | maximal heart rate estimation methods | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 31 |
Control; [cited 2024 Aug 18]. Available from: https://www.cdc.gov/heat-health/
hcp/clinical-guidance/heat-and-medications-guidance-for-clinicians.html. 22. Zhang Y, Coca A, Casa D, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569–74. doi:10.1016/j.jsams.
2014.07.01... | relationship between caffeine intake and hydration during sports | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | user-profile-optimize-prompt | 31 |
24. Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication
on-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
25. Kvarnström K, Westerholm A, Airaksinen M, Kiira H. Factors contributing to medication adherence in patient... | medication adherence in multimorbidity systematic review | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 32 |
24. Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication
on-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
25. Kvarnström K, Westerholm A, Airaksinen M, Kiira H. Factors contributing to medication adherence in patient... | predictors of medication non-adherence chronic conditions | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 32 |
24. Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication
on-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
25. Kvarnström K, Westerholm A, Airaksinen M, Kiira H. Factors contributing to medication adherence in patient... | factors influencing medication adherence in chronic diseases | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 32 |
24. Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication
on-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
25. Kvarnström K, Westerholm A, Airaksinen M, Kiira H. Factors contributing to medication adherence in patient... | qualitative research on medication adherence chronic illness | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 32 |
24. Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication
on-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987.
25. Kvarnström K, Westerholm A, Airaksinen M, Kiira H. Factors contributing to medication adherence in patient... | prevalence of medication non-adherence in multimorbidity | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 32 |
not have any financial disclosures.
Lauren R. Chaney, Pharm.D., BCPP, is a
clinical pharmacist practitioner at VA Augusta
Health Care System in Georgia. Dr. Chaney
has authored articles related to postpartum | postpartum health articles | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 33 |
not have any financial disclosures.
Lauren R. Chaney, Pharm.D., BCPP, is a
clinical pharmacist practitioner at VA Augusta
Health Care System in Georgia. Dr. Chaney
has authored articles related to postpartum | clinical pharmacist practitioner role in postpartum care | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 33 |
not have any financial disclosures.
Lauren R. Chaney, Pharm.D., BCPP, is a
clinical pharmacist practitioner at VA Augusta
Health Care System in Georgia. Dr. Chaney
has authored articles related to postpartum | VA Augusta Health Care System clinical pharmacy | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 33 |
not have any financial disclosures.
Lauren R. Chaney, Pharm.D., BCPP, is a
clinical pharmacist practitioner at VA Augusta
Health Care System in Georgia. Dr. Chaney
has authored articles related to postpartum | postpartum care pharmacy practices | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 33 |
not have any financial disclosures.
Lauren R. Chaney, Pharm.D., BCPP, is a
clinical pharmacist practitioner at VA Augusta
Health Care System in Georgia. Dr. Chaney
has authored articles related to postpartum | Pharm.D. authored postpartum health content | pharmacology_and_the_exercise_professional_.4.pdf | Physiology | knowledge-optimize-prompt | 33 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.